Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 6, Number 4, 2000

Book Reviews

Preface
pp. i-ii(2)
Author: Buolamwini, J.K.

Favourites:
ADD

Reviews

Favourites:
ADD

Cell Cycle Molecular Targets in Novel Anticancer Drug Discovery
pp. 379-392(14)
Author: Buolamwini, J.K.

Favourites:
ADD

MDM2 Oncogene as a Novel Target for Human Cancer Therapy
pp. 393-416(24)
Authors: Zhang, R.; Wang, H.

Favourites:
ADD

Angiogenesis New Targets for the Development of Anticancer Chemotherapies
pp. 417-439(23)
Authors: Gourley, M.; Williamson, J.S.

Favourites:
ADD

G-Quadruplex DNA as a Target for Drug Design
pp. 441-471(31)
Author: Kerwin, S.M.

Favourites:
ADD

Molecular Targets in Cancer Drug Discovery: Cell-Based Profiling
pp. 473-483(11)
Authors: Weinstein, J.N.; Buolamwini, J.K.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content